Enhanced antitumor effects of DC-activated CIKs to chemotherapy treatment in a single cohort of advanced non-small-cell lung cancer patients
Cancer Immunology, Immunotherapy, 07/03/2012
Yang L et al. – The present study suggests that dendritic cell (DC)–activated Cytokine–induced killer (CIK) cell has enhanced antitumor effects and chemotherapy plus DC+CIK cells improved the clinical outcomes of chemotherapy for advanced non–small–cell lung cancer (NSCLC) patients.



